Identification and characterization of cancer stem cells from head and neck squamous cell carcinoma cell lines

Cellular Physiology and Biochemistry

Volumn 36, Issue 2, 2015, Pages 784-798

  Pozzi, Valentina ^a   Sartini, Davide ^a   Rocchetti, Romina ^a   Santarelli, Andrea ^a,b   Rubini, Corrado ^a   Morganti, Stefano ^a   Giuliante, Rachela ^a   Calabrese, Stefania ^a   Di Ruscio, Giulia ^a   Orlando, Fiorenza ^b   Provinciali, Mauro ^b   Saccucci, Franca ^a   Muzio, Lorenzo Lo ^c   Emanuelli, Monica ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INRCA   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Cancer stem cells; Head and neck squamous cell carcinoma; Nicotinamide N Methyltransferase

Indexed keywords

CD133 ANTIGEN; HERMES ANTIGEN; NESTIN; NICOTINAMIDE METHYLTRANSFERASE; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER SIZE; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CELL COUNT; CELL DIVISION; CELL ISOLATION; CELL LEVEL; CELL PROLIFERATION; CELL SHAPE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEP 2 CELL LINE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL CULTURE; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; ENZYMOLOGY; HEAD AND NECK TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE; TUMOR CELL LINE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASTIC STEM CELLS; NICOTINAMIDE N-METHYLTRANSFERASE; TUMOR CELLS, CULTURED;

EID: 84930243078     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430138     Document Type: Article

References (64)

1. Argiris A, Karamouzis MV, Raben D, Ferris RL: Head and neck cancer. Lancet 2008;371:1695-1709.
2. Blagosklonny MV: Why therapeutic response may not prolong the life of a cancer patient: selection for oncogenic resistance. Cell Cycle 2005;4:1693-1698.
3. Yamano Y, Uzawa K, Saito K, Nakashima D, Kasamatsu A, Koike H, Kouzu Y, Shinozuka K, Nakatani K, Negoro K, Fujita S, Tanzawa H: Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma. Int J Cancer 2010;126:437-449.
4. Clarke MF, Fuller M: Stem cells and cancer: two faces of eve. Cell 2006;124:1111-1115.
5. Cho RW, Clarke MF: Recent advances in cancer stem cells. Curr Opin Genet Dev 2008;18:48-53.
6. Ailles L, Prince M: Cancer stem cells in head and neck squamous cell carcinoma. Methods Mol Biol 2009;568:175-193.
7. Dean M, Fojo T, Bates S: Tumour stem cells and drug resistance. Nat Rev Cancer 2005;5:275-284. review.
8. Jordan CT, Guzman ML, Noble M: Cancer stem cells. N Engl J Med 2006;355:1253-1261.
9. Dalerba P, Cho RW, Clarke MF: Cancer stem cells: models and concepts. Annu Rev Med 2007;58:267-284.
10. Pardal R, Clarke MF, Morrison SJ: Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003;3:895-902.
11. Tirino V, Desiderio V, d'Aquino R, De Francesco F, Pirozzi G, Graziano A, Galderisi U, Cavaliere C, De Rosa A, Papaccio G, Giordano A: Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS One 2008;3:e3469.
12. Kelly SE, Di Benedetto A, Greco A, Howard CM, Sollars VE, Primerano DA, Valluri JV, Claudio PP: Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications. PLoS One 2010;5:e10035.
13. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994;367:645-648.
14. Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-737.
15. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003;100:3983-3988.
16. Ponti D, Zaffaroni N, Capelli C, Daidone MG: Breast cancer stem cells: an overview. Eur J Cancer 2006;42:1219-1224.
17. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-5828.
18. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-760.
19. Ho MM, Ng AV, Lam S, Hung JY: Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007;67:4827-4833.
20. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT, Jacks T: Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121:823-835.
21. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005;65:10946-10951.
22. O'Brien CA, Pollett A, Gallinger S, Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445:106-110.
23. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 2007;104:10158-10163.
24. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007;1:313-323.
25. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PW, Lam CT, Poon RT, Fan ST: Significance of CD90+ Cancer Stem Cells In Human Liver Cancer. Cancer Cell 2008;13:153-166.
26. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007;104:973-978.
27. Wei XD, Zhou L, Cheng L, Tian J, Jiang JJ, Maccallum J: In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line. Head Neck 2009;31:94-101.
28. Zhang Q, Shi S, Yen Y, Brown J, Ta JQ, Le AD: A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett 2010;289:151-160.
29. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, Chou SH, Chien CS, Ku HH, Lo JF: Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 2008;14:4085-4095.
30. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA: Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006;9:391-403.
31. Zhong Y, Guan K, Guo S, Zhou C, Wang D, Ma W, Zhang Y, Li C, Zhang S: Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells. Cancer Lett 2010;299:150-160.
32. Balducci E, Orsomando G, Polzonetti V, Vita A, Emanuelli M, Raffaelli N, Ruggieri S, Magni G, Natalini P: NMN adenylyltransferase from bull testis: purification and properties. Biochem J 1995;310:395-400
33. Monroe MM, Anderson EC, Clayburgh DR, Wong MH: Cancer stem cells in head and neck squamous cell carcinoma. J Oncol 2011;2011:762780.
34. Lippman SM, Sudbo J, Hong WK: Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol 2005;23:346-356.
35. Le Tourneau C: Molecularly targeted therapy in head and neck cancer. Bull Cancer 2010;97:1453-1466.
36. Graziano A, D'Aquino R, Tirino V, Desiderio V, Rossi A, Pirozzi G: The stem cell hypothesis in head and neck cancer. J Cell Biochem 2008;103:408-412.
37. Chinn SB, Darr OA, Peters RD, Prince ME: The role of head and neck squamous cell carcinoma cancer stem cells in tumorigenesis, metastasis, and treatment failure. Front Endocrinol 2012;3:90.
38. Zhang Z, Filho MS, Nor JE: The biology of head and neck cancer stem cells. Oral Oncol 2012;48:1-9.
39. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB: Identification of human brain tumour initiating cells. Nature 2004;432:396-401.
40. He QZ, Luo XZ, Wang K, Zhou Q, Ao H, Yang Y, Li SX, Li Y, Zhu HT, Duan T: Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas. Cell Physiol Biochem 2014;33:173-84.
41. Xu J, Fan W, Tu XX, Zhang T, Hou ZJ, Guo T, Shu X, Luo X, Liu Y, Peng F, Wang C, Xu L, Zhou H, Liu Q: Neural ganglioside GD2(+) cells define a subpopulation of mesenchymal stem cells in adult murine bone marrow. Cell Physiol Biochem 2013;32:889-98.
42. Zhou L, Wei X, Cheng L, Tian J, Jiang JJ: CD133, one of the markers of cancer stem cells in Hep-2 cell line. Laryngoscope 2007;117:455-460.
43. Pries R, Witrkopf N, Trenkle T, Nitsch SM, Wollenberg B: Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer. In Vivo 2008;22:89-92.
44. Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon LY: CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope 2009;119:1518-1530.
45. Aksoy S, Szumlanski CL, Weinshilboum RM: Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. J Biol Chem 1994;269:14835-14840.
46. Peng Y, Sartini D, Pozzi V, Wilk D, Emanuelli M, Yee VC: Structural basis of substrate recognition in human nicotinamide N-methyltransferase. Biochemistry 2011;50:7800-7808.
47. Markert JM, Fuller CM, Gillespie GY, Bubien JK, McLean LA, Hong RL, Lee K, Gullans SR, Mapstone TB, Benos DJ: Differential gene expression profiling in human brain tumors. Physiol Genomics 2001;5:21-33.
48. Jang JS, Cho HY, Lee YJ, Ha WS, Kim HW: The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res 2004;14:491-499.
49. Lim BH, Cho BI, Kim YN, Kim JW, Park ST, Lee CW: Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification. Exp Mol Med 2006;38:455-465.
50. Xu J, Moatamed F, Caldwell JS, Walker JR, Kraiem Z, Taki K, Brent GA, Hershman JM: Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells. J Clin Endocrinol Metab 2003;88:4990-4996.
51. Xu J, Capezzone M, Xu X, Hershman JM: Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells. Mol Endocrinol 2005;19:527-539.
52. Sartini D, Muzzonigro G, Milanese G, Pierella F, Rossi V, Emanuelli M: Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma. J Urol 2006;176:2248-2254.
53. Yao M, Tabuchi H, Nagashima Y, Baba M, Nakaigawa N, Ishiguro H, Hamada K, Inayama Y, Kishida T, Hattori K, Yamada-Okabe H, Kubota Y: Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J Pathol 2005;205:377-387.
54. Sartini D, Santarelli A, Rossi V, Goteri G, Rubini C, Ciavarella D, Lo Muzio L, Emanuelli M: Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma. Mol Med 2007;13:415-421.
55. Emanuelli M, Santarelli A, Sartini D, Ciavarella D, Rossi V, Pozzi V, Rubini C, Lo Muzio L: Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma. Histol Histopathol 2010;25:15-20.
56. Sartini D, Pozzi V, Renzi E, Morganti S, Rocchetti R, Rubini C, Santarelli A, Lo Muzio L, Emanuelli M: Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease. Biol Chem 2012;393:505-511.
57. Roessler M, Rollinger W, Palme S, Hagmann ML, Berndt P, Engel AM, Schneidinger B, Pfeffer M, Andres H, Karl J, Bodenmuller H, Ruschoff J, Henkel T, Rohr G, Rossol S, Rosch W, Langen H, Zolg W, Tacke M: Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer Clin Cancer Res 2005;11:6550-6557.
58. Sartini D, Muzzonigro G, Milanese G, Pozzi V, Vici A, Morganti S, Rossi V, Mazzucchelli R, Montironi R, Emanuelli M: Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. Cell Biochem Biophys 2012;65:473-483.
59. Tomida M, Mikami I, Takeuchi S, Nishimura H, Akiyama H: Serum levels of nicotinamide N-methyltransferase in patients with lung cancer. J Cancer Res Clin Oncol 2009;135:1223-1229.
60. Sartini D, Morganti S, Guidi E, Rubini C, Zizzi A, Giuliante R, Pozzi V, Emanuelli M: Nicotinamide N-methyltransferase in Non-small Cell Lung Cancer: Promising Results for Targeted Anti-cancer Therapy. Cell Biochem Biophys 2013 Mar 27;67:865-873.
61. Rogers CD, Fukushima N, Sato N, Shi C, Prasad N, Hustinx SR, Matsubayashi H, Canto M, Eshleman JR, Hruban RH, Goggins M: Differentiating pancreatic lesions by microarray and QPCR analysis of pancreatic juice RNAs. Cancer Biol Ther 2006;5:1383-1389.
62. Pozzi V, Mazzotta M, Lo Muzio L, Sartini D, Santarelli A, Renzi E, Rocchetti R, Tomasetti M, Ciavarella D, Emanuelli M: Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. Int J Immunopathol Pharmacol 2011;24:69-77.
63. Pozzi V, Sartini D, Morganti S, Giuliante R, Di Ruscio G, Santarelli A, Rocchetti R, Rubini C, Tomasetti M, Giannatempo G, Orlando F, Provinciali M, Lo Muzio L, Emanuelli M: RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells. PLoS One 2013;8:e71272.
64. Sartini D, Seta R, Pozzi V, Morganti S, Rubini C, Zizzi A, Tomasetti M, Santarelli L, Emanuelli M: Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumourigenicity. Biol Chem 2015;396:225-234.